Christensen Gustav 4

What Happened Gustav Christensen, a director of Generation Bio Co. (GBIO), disposed of a total of 33,262 shares on Feb 9, 2026 as part of the company’s tender offer and merger with XOMA Royalty Corporation. The shares were exchanged for $4.2913 per share in cash (approximately $142,737) plus one non-tradeable contingent value right (CVR) per share. The CVRs carry an estimated maximum contingent payment of $25.01 each, meaning the contingent component could add up to roughly $831,883 and bring the total potential consideration to about $975,000. Some of the reported dispositions were labeled as derivative transactions — reflecting automatic cash settlement/cancellation of in‑the‑money options under the merger agreement.

Key Details

• Transaction date: February 9, 2026 (Effective Time of the merger).
• Shares disposed: 33,262 total (individual line items shown on the Form 4).
• Cash price: $4.2913 per share; immediate cash received ≈ $142,737.
• CVR: one non‑tradeable CVR per share; estimated maximum contingent value $25.01/CVR (additional potential ≈ $831,883).
• Transaction codes on the filing: U (change in control disposition) and D (disposition to the issuer); several dispositions marked as derivative (resulting from option cancellation/settlement).
• Shares owned after the transaction: not specified in the Form 4.
• Filing timeliness: Form 4 filed on Feb 9, 2026 (same date as the transactions), indicating timely reporting.

Context

• This was a merger/tender-offer settlement, not an open‑market sale; proceeds were paid by the acquirer per the Merger Agreement (cash + CVR). Under the agreement, in‑the‑money options were converted into cash payments and out‑of‑the‑money options were cancelled for no consideration.
• Such merger-related dispositions are routine corporate-transaction outcomes and do not, by themselves, indicate the insider’s view on future stock performance.